{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:47:10Z","timestamp":1782604030036,"version":"3.54.5"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/spc.0b013e3283640f5f","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T12:26:58Z","timestamp":1375360018000},"page":"265-271","source":"Crossref","is-referenced-by-count":8,"title":["Managing hypercalcaemia and hypocalcaemia in cancer patients"],"prefix":"10.1097","volume":"7","author":[{"given":"Nazanin","family":"Fallah-Rad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ross","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20211004","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.2215\/CJN.05910809","article-title":"Calcium metabolism in health and disease.","volume":"5","author":"Peacock","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-6-20211004","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00520-012-1683-5","article-title":"Nonmalignant causes of Hypercalcaemia in cancer patients: a frequent and neglected occurrence.","volume":"21","author":"Soyfoo","year":"2013","journal-title":"Support Cancer Care"},{"key":"R3-6-20211004","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcaemia associated with cancer.","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"key":"R4-6-20211004","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1210\/jc.2012-2142","article-title":"Parathyroid hormone related peptide: An update.","volume":"97","author":"Wysolmerski","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-6-20211004","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5312\/wjo.v3.i11.175","article-title":"New roles of osteoblasts involved in osteoclast differentiation.","volume":"3","author":"Yamashita","year":"2012","journal-title":"World J Orthop"},{"key":"R6-6-20211004","doi-asserted-by":"crossref","first-page":"838614","DOI":"10.5402\/2012\/838614","article-title":"Predictors of hypocalcemia after thyroidectomy: results from the nationwide inpatient sample.","volume":"2012","author":"Baldassarre","year":"2012","journal-title":"ISRN Surg"},{"key":"R7-6-20211004","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00520-012-1461-4","article-title":"Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients.","volume":"20","author":"Dranitsaris","year":"2012","journal-title":"Support Care Cancer"},{"key":"R8-6-20211004","first-page":"607","article-title":"Vitamin D deficiency in oncology patients - an ignored condition: Impact on hypocalcemia and quality of life.","volume":"14","author":"Segal","year":"2012","journal-title":"Isr Med Assoc J"},{"key":"R9-6-20211004","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-149-4-200808190-00007","article-title":"Narrative review: furosemide for Hypercalcaemia: an unproven yet common practice.","volume":"149","author":"LeGrand","year":"2008","journal-title":"Ann Intern Med"},{"key":"R10-6-20211004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/bcr414","article-title":"Development of bisphosphonates.","volume":"4","author":"Fleisch","year":"2002","journal-title":"Breast Cancer Res Commun"},{"key":"R11-6-20211004","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s12032-010-9461-z","article-title":"Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study.","volume":"28","author":"Sabry","year":"2011","journal-title":"Med Oncol"},{"key":"R12-6-20211004","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1200\/JCO.2012.41.7923","article-title":"Denosumab for the treatment of bisphosphonate-refractory Hypercalcaemia.","volume":"30","author":"Boikos","year":"2012","journal-title":"J Clin Oncol"},{"key":"R14-6-20211004","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1210\/er.2008-0041","article-title":"The role of the calcium-sensing receptor in the development and progression of cancer.","volume":"30","author":"Saidak","year":"2009","journal-title":"Endocrine Reviews"},{"key":"R15-6-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000335676","article-title":"Cinacalcet for Hypercalcaemia caused by pulmonary squamous cell carcinoma producing parathyroid hormone-related peptide.","volume":"5","author":"Bech","year":"2012","journal-title":"Case Rep Oncol"},{"key":"R16-6-20211004","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.","volume":"92","author":"Silverberg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-6-20211004","doi-asserted-by":"crossref","first-page":"1174e1","DOI":"10.1016\/j.ajem.2009.01.026","article-title":"Hypercalcemic crisis successfully treated with prompt calcium-free hemodialysis.","volume":"27","author":"Wang","year":"2009","journal-title":"Amer J of Emerg Med"},{"key":"R18-6-20211004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00130404-200601000-00009","article-title":"Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related Hypercalcaemia.","volume":"12","author":"Cvitkovic","year":"2006","journal-title":"Cancer J"},{"key":"R19-6-20211004","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/1049909111414164","article-title":"Modern management of malignant Hypercalcaemia.","volume":"28","author":"LeGrand","year":"2011","journal-title":"Amer J Hospice and Palliative Med"},{"key":"R20-6-20211004","first-page":"158","article-title":"Hypocalcemia.","volume":"58","author":"Fong","year":"2012","journal-title":"Canadian Fam Phys"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201309000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T05:44:09Z","timestamp":1633499049000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201309000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0b013e3283640f5f","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}